S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
His system isolated NVIDIA - Here's His Next Buy. (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
His system isolated NVIDIA - Here's His Next Buy. (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
His system isolated NVIDIA - Here's His Next Buy. (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
His system isolated NVIDIA - Here's His Next Buy. (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
His system isolated NVIDIA - Here's His Next Buy. (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
His system isolated NVIDIA - Here's His Next Buy. (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
His system isolated NVIDIA - Here's His Next Buy. (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
His system isolated NVIDIA - Here's His Next Buy. (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
NASDAQ:TRHC

Tabula Rasa HealthCare (TRHC) Stock Forecast, Price & News

$10.31
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$10.31
$10.37
50-Day Range
$7.66
$10.33
52-Week Range
$3.15
$10.37
Volume
143,628 shs
Average Volume
423,415 shs
Market Capitalization
$278.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

Tabula Rasa HealthCare MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
22.4% Downside
$8.00 Price Target
Short Interest
Healthy
3.19% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.80mentions of Tabula Rasa HealthCare in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars

Medical Sector

860th out of 963 stocks

Business Services, Not Elsewhere Classified Industry

79th out of 89 stocks


TRHC stock logo

About Tabula Rasa HealthCare (NASDAQ:TRHC) Stock

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

TRHC Price History

TRHC Stock News Headlines

This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Tabula Rasa HealthCare Inc. News
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Why Are Tabula Rasa HealthCare Shares Moving Higher Today?
Earnings Outlook For Tabula Rasa HealthCare
See More Headlines
Receive TRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

TRHC Company Calendar

Last Earnings
8/07/2023
Today
9/24/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRHC
Fax
N/A
Employees
1,027
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
-22.4%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$-147,510,000.00
Pretax Margin
-17.99%

Debt

Sales & Book Value

Annual Sales
$299.52 million
Book Value
($2.10) per share

Miscellaneous

Free Float
18,857,000
Market Cap
$278.99 million
Optionable
Optionable
Beta
1.60
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Brian W. AdamsMr. Brian W. Adams (Age 41)
    CEO, Pres & Director
    Comp: $668.21k
  • Mr. Thomas J. Cancro C.F.A. (Age 55)
    CPA, Chief Financial Officer
    Comp: $523.42k
  • Mr. Michael Greenhalgh BScPharm (Age 61)
    RPh, COO & Pres of Pharmacy Services
    Comp: $630.9k
  • Mr. Michael Bruno (Age 35)
    VP, Corp. Controller & Chief Accounting Officer
  • Mr. Bob Sullivan M.S.
    Chief Technology Officer
  • Mr. Phillip W. Heath MS (Age 57)
    Chief Admin. Officer
  • Mr. Frank Sparacino C.F.A.
    CPA, Sr. VP of Investor Relations & Corp. Devel.
  • Mr. Richard W. Rew II (Age 55)
    Chief Legal Officer & Corp. Sec.
  • Ms. Kathleen D Larkin M.B.A.
    Chief People Officer
  • Ms. Andrea Carolan Speers M.S.Ms. Andrea Carolan Speers M.S. (Age 42)
    Chief of Staff













TRHC Stock - Frequently Asked Questions

Should I buy or sell Tabula Rasa HealthCare stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TRHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View TRHC analyst ratings
or view top-rated stocks.

What is Tabula Rasa HealthCare's stock price forecast for 2023?

5 brokerages have issued 12-month price objectives for Tabula Rasa HealthCare's shares. Their TRHC share price forecasts range from $6.00 to $10.00. On average, they predict the company's stock price to reach $8.00 in the next twelve months. This suggests that the stock has a possible downside of 22.4%.
View analysts price targets for TRHC
or view top-rated stocks among Wall Street analysts.

How have TRHC shares performed in 2023?

Tabula Rasa HealthCare's stock was trading at $4.95 at the beginning of the year. Since then, TRHC shares have increased by 108.3% and is now trading at $10.31.
View the best growth stocks for 2023 here
.

Are investors shorting Tabula Rasa HealthCare?

Tabula Rasa HealthCare saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 763,200 shares, a decrease of 21.2% from the August 15th total of 969,000 shares. Based on an average trading volume of 376,400 shares, the short-interest ratio is presently 2.0 days. Currently, 3.2% of the company's stock are sold short.
View Tabula Rasa HealthCare's Short Interest
.

When is Tabula Rasa HealthCare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our TRHC earnings forecast
.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) released its earnings results on Monday, August, 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.24. The firm earned $90.04 million during the quarter, compared to analyst estimates of $88.82 million.

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a number of retail and institutional investors. Top institutional investors include Wasatch Advisors LP (4.28%), Kent Lake Capital LLC (2.22%), Acadian Asset Management LLC (1.66%), Portside Wealth Group LLC (1.59%), Kennedy Capital Management LLC (1.34%) and Repertoire Partners LP (1.29%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro.
View institutional ownership trends
.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $10.31.

How much money does Tabula Rasa HealthCare make?

Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $278.99 million and generates $299.52 million in revenue each year. The company earns $-147,510,000.00 in net income (profit) each year or ($3.85) on an earnings per share basis.

How many employees does Tabula Rasa HealthCare have?

The company employs 1,027 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com.

This page (NASDAQ:TRHC) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -